David Palomino-Fernández1, Adolfo Gómez-Grande2,3, Mirene Fernández-Igarza1, Patrick Pilkington2, Alexander P Seiffert1, Héctor Bueno3,4,5,6, Enrique J Gómez1,7, Patricia Sánchez-González8,9. 1. Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain. 2. Department of Nuclear Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain. 3. Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. 4. Cardiology Department and Instituto de Investigación Sanitaria (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain. 5. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. 6. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. 7. Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain. 8. Biomedical Engineering and Telemedicine Centre, ETSI Telecomunicación, Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid, Spain. p.sanchez@upm.es. 9. Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain. p.sanchez@upm.es.
Abstract
PURPOSE: Due to the high morbidity and mortality of infective endocarditis (IE), medical imaging techniques are combined to ensure a correct diagnosis. [18F]FDG PET/CT has demonstrated the ability to improve diagnostic accuracy compared with the conventional modified Duke criteria in patients with suspected IE, especially those with prosthetic valve infective endocarditis (PVIE). The aim of this study is to provide an adjunctive diagnostic tool to improve the diagnostic accuracy in cardiovascular infections, specifically PVIE. METHODS: A segmentation tool to extract quantitative measures of [18F]FDG PET/CT image studies of prosthetic heart valve regions was developed and validated in 20 cases of suspected PVIE, of which 9 were confirmed. For that, Valvular Heterogeneity Index (VHI) and Ring-to-Center Ratio (RCR) were defined. RESULTS: Results show an overall increase in the metabolic uptake of the prosthetic valve ring in the studies with confirmed PVIE diagnosis (SUVmax from 1.70 to 3.20; SUVmean from 0.86 to 1.50). The VHI and RCR showed areas under the curve of 0.727 and 0.808 in the receiver operating characteristics curve analyses, respectively, for PVIE diagnosis. Mann-Whitney U tests showed statistically significant differences between groups for RCR (p = 0.02). Visual analyses and clinical reports were concordant with the extracted quantitative metrics. CONCLUSION: The proposed new method and presented software solution (CASSIA) provide the capability to assess quantitatively myocardial metabolism along the prosthetic valve region in routine [18F]FDG PET/CT scans for evaluating heart valve infectious processes. VHI and RCR are proposed as new potential adjunctive measures for PVIE diagnosis.
PURPOSE: Due to the high morbidity and mortality of infective endocarditis (IE), medical imaging techniques are combined to ensure a correct diagnosis. [18F]FDG PET/CT has demonstrated the ability to improve diagnostic accuracy compared with the conventional modified Duke criteria in patients with suspected IE, especially those with prosthetic valve infective endocarditis (PVIE). The aim of this study is to provide an adjunctive diagnostic tool to improve the diagnostic accuracy in cardiovascular infections, specifically PVIE. METHODS: A segmentation tool to extract quantitative measures of [18F]FDG PET/CT image studies of prosthetic heart valve regions was developed and validated in 20 cases of suspected PVIE, of which 9 were confirmed. For that, Valvular Heterogeneity Index (VHI) and Ring-to-Center Ratio (RCR) were defined. RESULTS: Results show an overall increase in the metabolic uptake of the prosthetic valve ring in the studies with confirmed PVIE diagnosis (SUVmax from 1.70 to 3.20; SUVmean from 0.86 to 1.50). The VHI and RCR showed areas under the curve of 0.727 and 0.808 in the receiver operating characteristics curve analyses, respectively, for PVIE diagnosis. Mann-Whitney U tests showed statistically significant differences between groups for RCR (p = 0.02). Visual analyses and clinical reports were concordant with the extracted quantitative metrics. CONCLUSION: The proposed new method and presented software solution (CASSIA) provide the capability to assess quantitatively myocardial metabolism along the prosthetic valve region in routine [18F]FDG PET/CT scans for evaluating heart valve infectious processes. VHI and RCR are proposed as new potential adjunctive measures for PVIE diagnosis.
Authors: D Raoult; J P Casalta; H Richet; M Khan; E Bernit; C Rovery; S Branger; F Gouriet; G Imbert; E Bothello; F Collart; G Habib Journal: J Clin Microbiol Date: 2005-10 Impact factor: 5.948
Authors: G Habib; G Derumeaux; J F Avierinos; J P Casalta; F Jamal; F Volot; M Garcia; J Lefevre; F Biou; A Maximovitch-Rodaminoff; P E Fournier; P Ambrosi; J G Velut; A Cribier; J R Harle; P J Weiller; D Raoult; R Luccioni Journal: J Am Coll Cardiol Date: 1999-06 Impact factor: 24.094
Authors: Gilbert Habib; Luigi Badano; Christophe Tribouilloy; Isidre Vilacosta; Jose Luis Zamorano; Maurizio Galderisi; Jens-Uwe Voigt; Rosa Sicari; Bernard Cosyns; Kevin Fox; Svend Aakhus Journal: Eur J Echocardiogr Date: 2010-03
Authors: Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Ulises Granados; David Fuster; Juan M Pericas; Jaime L Llopis; Salvador Ninot; Eduard Quintana; Manel Almela; Carlos Paré; José M Tolosana; Carlos Falces; Asuncion Moreno; Francesca Pons; Francisco Lomeña; Jose M Miro Journal: J Nucl Med Date: 2016-06-03 Impact factor: 10.057